Skip to main content

Advertisement

Log in

Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Although minimally invasive techniques for distal pancreatectomy with or without splenectomy have been regarded as a feasible and safe treatment option for benign and borderline malignant lesions of the pancreas, the management of left-sided pancreatic cancer remains controversial.

Methods

From June 2007 to November 2010, 12 patients underwent laparoscopic or robotic radical antegrade modular pancreatosplenectomy (RAMPS) for well-selected left-sided pancreatic cancer. The Yonsei criteria for patient selection included the following conditions: (1) tumor confined to the pancreas, (2) intact fascial layer between the distal pancreas and the left adrenal gland and kidney, and (3) tumor located more than 1–2 cm from the celiac axis. We compared the clinicopathologic factors and oncologic outcomes of the minimally invasive surgery (MIS) and the conventional open surgery groups for treating left-sided pancreatic cancer.

Results

In the MIS group, the mean tumor size was 2.75 ± 1.32 cm, and the mean number of retrieved lymph nodes was 10.5 ± 7.14. The resection margins were confirmed to be negative for malignancy in all patients. The MIS group and open group (n = 78) were statistically different in terms of tumor size (2.8 ± 1.3 vs. 3.5 ± 1.9 cm, p = 0.05) and length of hospital stay (12.3 ± 6.8 vs. 22.4 ± 21.6 days, p = 0.002). On survival analysis, the MIS group had longer disease-free survival (DFS) and overall survival (OS) than the open group (DFS: 47.6 vs. 24.7 months, p = 0.027; OS: 60.0 vs. 30.7 months, p = 0.046). In order to overcome the heterogeneity of subjects between the MIS and the open group, we performed statically matched comparisons using the propensity score analysis and then divided the open group into two subgroups according to the Yonsei criteria. There were no significant differences in median overall survival between the MIS group and the open group that met the Yonsei criteria (60.00 vs. 60.72 months, p = 0.616).

Conclusions

Minimally invasive RAMPS is not only technically feasible but also oncologically safe in cases of well-selected left-sided pancreatic cancer. Our selection criteria for minimally invasive RAMPS needs to be further validated based on additional large-volume studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Merchant NB, Parikh AA, Kooby DA (2009) Should all distal pancreatectomies be performed laparoscopically? Adv Surg 43:283–300

    Article  PubMed  Google Scholar 

  2. Kang CM, Kim DH, Lee WJ (2010) Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc 24:1533–1541

    Article  PubMed  Google Scholar 

  3. Choi SH, Kang CM, Lee WJ (2011) Laparoscopic modified anterior RAMPS in well-selected left-sided pancreatic cancer: technical feasibility and interim results. Surg Endosc 25:2360–2361

    Article  PubMed  Google Scholar 

  4. Choi SH, Kang CM, Hwang HK et al (2012) Robotic anterior RAMPS in well-selected left-sided pancreatic cancer. J Gastrointest Surg 16:868–869

    Article  PubMed  Google Scholar 

  5. Lillemoe KD, Kaushal S, Cameron JL et al (1999) Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 229:693–698

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Fernandez-del Castillo C, Rattner DW, Warshaw AL (1995) Standards for pancreatic resection in the 1990s. Arch Surg 130:295–299

  7. Strasberg SM, Drebin JA, Linehan D (2003) Radical antegrade modular pancreatosplenectomy. Surgery 133:521–527

    Article  PubMed  Google Scholar 

  8. Strasberg SM, Linehan DC, Hawkins WG (2007) Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg 204:244–249

    Article  PubMed  Google Scholar 

  9. O’Morchoe CC (1997) Lymphatic system of the pancreas. Microsc Res Tech 37:456–477

    Article  PubMed  Google Scholar 

  10. Mitchem JB, Hamilton N, Strasberg SM et al (2012) Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg 214:46–52

    Article  PubMed  Google Scholar 

  11. Choi SH, Kang CM, Kim JY et al (2013) Laparoscopic extended (subtotal) distal pancreatectomy with resection of both splenic artery and vein. Surg Endosc 27:1412–1413

    Article  PubMed  Google Scholar 

  12. Kang CM, Choi SH, Hwang HK et al (2010) Laparoscopic distal pancreatectomy with division of the pancreatic neck for benign and borderline malignant tumor in the proximal body of the pancreas. J Laparoendosc Adv Surg Technol A 20:581–586

    Article  CAS  Google Scholar 

  13. Hayashi H, Ochiai T, Shimada H et al (2005) Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer. Surg Endosc 19:1172–1176

    Article  PubMed  CAS  Google Scholar 

  14. Cho A, Yamamoto H, Kainuma O et al (2011) Pure laparoscopic distal pancreatectomy with en bloc celiac axis resection. J Laparoendosc Adv Surg Technol A 21:957–959

    Article  Google Scholar 

  15. Takahashi S, Kinoshita T, Konishi M et al (2011) Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment. J Hepatobiliary Pancreat Sci 18:567–574

    Article  PubMed  Google Scholar 

  16. Stokes JB, Nolan NJ, Stelow EB et al (2011) Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol 18:619–627

    Article  PubMed  Google Scholar 

  17. Kang CM, Chung YE, Park JY et al (2012) Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer. J Gastrointest Surg 16:509–517

    Article  PubMed  Google Scholar 

  18. Rosales-Velderrain A, Bowers SP, Goldberg RF et al (2012) National trends in resection of the distal pancreas. World J Gastroenterol 18:4342–4349

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sui CJ, Li B, Zhou YM et al (2012) Laparoscopic versus open distal pancreatectomy: a meta-analysis. Asian J Surg 35:1–8

    Article  PubMed  Google Scholar 

  20. Fisher SB, Kooby DA (2013) Laparoscopic pancreatectomy for malignancy. J Surg Oncol 107:39–50

    Article  PubMed  Google Scholar 

  21. Edge SB, Stephen B (2010) Exocrine and endocrine pancreas. In: Edge SB, Byrd DR, Compton CC et al (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 241–249

    Google Scholar 

  22. Bilimoria KY, Bentrem DJ, Ko CY et al (2007) National failure to operate on early stage pancreatic cancer. Ann Surg 246:173–180

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wasif N, Ko CY, Tomlinson JS et al (2010) Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol 17:2312–2320

    Article  PubMed  PubMed Central  Google Scholar 

  24. Almhanna K, Philip PA (2011) Defining new paradigms for the treatment of pancreatic cancer. Curr Treat Options Oncol 12:111–125

    Article  PubMed  Google Scholar 

  25. Sarris EG, Syrigos KN, Saif MW (2013) Pancreatic cancer: updates on translational research and future applications. JOP 14:145–148

    PubMed  Google Scholar 

  26. Kooby DA, Gillespie T, Bentrem D et al (2008) Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 248:438–446

    PubMed  Google Scholar 

Download references

Disclosures

Drs. Sung Hwan Lee, Chang Moo Kang, Ho Kyoung Hwang, Sung Hoon Choi, Woo Jung Lee, and Hoon Sang Chi have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chang Moo Kang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S.H., Kang, C.M., Hwang, H.K. et al. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc 28, 2848–2855 (2014). https://doi.org/10.1007/s00464-014-3537-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-014-3537-3

Keywords

Navigation